(see also Figure 1 ) Development of pathology in the cortex of TAU, TASTPM, TAS10 and TPM transgenic mice. Representative images of cortex immunostained with Aβ-40 or AT8 (phosphorylated tau) antibodies (green) and nuclear stain DAPI (blue). TAU mice show phosphorylated tau in neurons and dendrites usually beginning at 8 months of age. At 18 months, majority of neurons contain phosphorylated tau in the cell body. HO-TASTPM mice show early and rapid development of amyloid plaques. HET-TASTPM show slower development of mature plaques beginning at 8 months of age. (Rare small plaques seen at 4 months in most mice.) TAS10 (APP) mice develop sparse hippocampal plaques by 18 months of age. TPM (PSEN1) mice show no evidence of amyloid deposition by 18 months. Inset Semi-quantitative score based on pathology severity (0-5) of all groups. Error bars: SEM. Scale bar 50 μm. Figure 4 ) Validation of the microarray data using qPCR. mRNA levels of a selection of differentially expressed genes was measured using qPCR. The circles represent the microarray data. The filled columns represent qPCR results using the same mRNA samples as was used for the microarrays while the open columns represent qPCR of mRNA samples from different animals prepared independently in a different lab from a different colony of TASTPM and TAU mice. All relative expression (48 groups of mice) was consistent between microarrays and qPCR on the same mice. Independent samples were also consistent in most cases although some difference was seen in the 4 month data for Slc17a6 and Rims2. For qPCR n=3-5. Error bars: SEM. Figure 4) p-values and fold changes for the known risk genes for AD according to dementia mouse model, age and brain region. Genes that were differentially expressed (FDR < 0.01) are highlighted; increased expression, red; decreased expression, green. Dementia mouse models, ages and regions that do not show a minimum of one gene differently expressed by >1.5 fold when compared to wild-type mice are not shown. Figure 2) Frequency of large gene expression changes in all groups. Number of genes with >2-fold (upper panels) or >1.5-fold (lower panels) increased (red) or decreased (green) expression compared to wild-type in all groups of mice (FDR < 0.05) at ages indicated. Figure 2) The top annotation categories of the differentially expressed genes which are common between TAU and HO-TASTPM mice or unique to one or the other. Where full categories are significantly altered the category name is stated. Otherwise the absolute number of altered genes is stated with relevant genes with greatest alteration specified. The presence of amyloid plaques or tau neurofibrillary tangles is indicated by the arrows below the table. . Categories are characterised by the Enrichment Analysis Systematic Explorer (EASE) program in DAVID. Colours: For genes unique to one genotype HO-TASTPM, red; TAU, blue and purple for overlapping genes. Figure 6 ) Definition of most significant GO categories with significance levels for the M1 'immune' and M2 'synaptic' modules defined by network analysis.
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